Study guide

6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies

Medical Council of Canada Qualifying Examination Part I MCCQE Part I

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Blueprint & Canadian Medical Practice

1.1 MCCQE Part I Format, Scoring (439 Scale), & Strategy 1.2 The MCC Blueprint Matrix: Dimensions of Care & Physician Activities 1.3 Canadian Healthcare System, CanMEDS Roles, & Interprofessional Care 1.4 Evidence-Based Medicine, Study Design, & Clinical Statistics

2 Chapter 2: Population Health, Health Promotion & Preventive Care

2.1 Canadian Task Force on Preventive Health Care (CTFPHC) Screening Guidelines 2.2 Immunization Schedules (NACI) & Vaccine-Preventable Diseases across Lifespan 2.3 Disease Prevention, Lifestyle Counselling, & Harm Reduction 2.4 Outbreak Management, Disease Surveillance, & Infection Control 2.5 Occupational, Environmental, & Travel Medicine in Canada

3 Chapter 3: Internal Medicine — Cardiovascular & Respiratory Systems

3.1 Hypertension Canada 2020/2025 Guidelines, Dyslipidemia, & Primary Prevention 3.2 Ischemic Heart Disease, Acute Coronary Syndromes, & Heart Failure Management 3.3 Arrhythmias, Valvular Heart Disease, & Infective Endocarditis 3.4 Asthma, COPD, & Respiratory Failure (CTS Guidelines) 3.5 Thromboembolic Disease (DVT/PE), Pneumonia, & Pleural Effusions

4 Chapter 4: Internal Medicine — GI, Endocrine, Renal & Hematology/Oncology

4.1 Gastrointestinal Disorders, Acute Abdomen, & Liver/Biliary Disease 4.2 Diabetes Canada 2020/2025 Guidelines & Glycemic Management 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances 4.4 Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), & Nephrology 4.5 Hematology, Anemia Evaluation, Transfusion Medicine, & Common Cancers

5 Chapter 5: General Surgery, Orthopedics, & Emergency Care

5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications 5.2 Trauma Management (ATLS Protocol) & Burns 5.3 Acute Surgical Conditions (Appendicitis, Cholecystitis, Bowel Obstruction) 5.4 Fractures, Dislocations, Joint Pain, & Musculoskeletal Emergencies 5.5 Vascular Emergencies, Wound Care, & Shock Recognition

6 Chapter 6: Pediatrics & Adolescent Health

6.1 Pediatric Growth, Developmental Milestones, & Well-Child Examinations 6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies 6.3 Pediatric Respiratory Emergencies (Croup, Bronchiolitis, Asthma) 6.4 Common Pediatric Infections, Exanthems, & Fever of Unknown Origin 6.5 Pediatric Abdominal Pain, Dehydration, & Fluid Management

7 Chapter 7: Obstetrics & Gynecology

7.1 Routine Antepartum Care, Screening, & Prenatal Diagnosis (SOGC Guidelines) 7.2 Medical Complications of Pregnancy (Preeclampsia, Gestational Diabetes, Infections) 7.3 Labor, Intrapartum Management, & Postpartum Complications/Hemorrhage 7.4 Abnormal Uterine Bleeding, Gynecologic Infections, & Contraception/Menopause 7.5 Gynecologic Oncology & Pelvic Mass Evaluation

8 Chapter 8: Psychiatry & Mental Health

8.1 Mood Disorders (Depression, Bipolar) & Suicide Risk Assessment 8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders 8.3 Psychotic Disorders & Schizophrenia Management 8.4 Substance Use Disorders, Withdrawal Syndromes, & Harm Reduction 8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)

9 Chapter 9: Neurology, Rheumatology, & Dermatology

9.1 Acute Stroke, TIA, & Neurovascular Emergencies 9.2 Headaches, Seizures, Movement Disorders, & Neuromuscular Disease 9.3 Inflammatory Arthritides (RA, Gout, SpA) & Systemic Autoimmune Diseases (SLE, Vasculitis) 9.4 Common Dermatologic Conditions, Cutaneous Manifestations of Systemic Disease, & Skin Cancers 9.5 Musculoskeletal Soft Tissue Injuries, Back Pain, & Physical Medicine

10 Chapter 10: Legal, Ethical, & Professional Behaviours in Canadian Practice

10.1 Informed Consent, Capacity Assessment, & Substitute Decision-Making (CMPA) 10.2 Medical Confidentiality, Privacy Laws (PIPEDA/PHIPA), & Disclosure of Harm 10.3 CMA Code of Ethics, Professionalism, & Physician Health/Boundary Issues 10.4 Mandatory Reporting (Child/Elder Abuse, Driving Safety, Fitness to Practice) & Quality/Safety

6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies

Key Takeaways Explain This Topic AI

NRP 8th Edition algorithm prioritizes effective positive pressure ventilation (PPV) within the first 60 seconds ("golden minute") for non-breathing or gasping neonates or HR < 100 bpm.

Neonatal jaundice appearing in the first 24 hours of life is ALWAYS pathological and requires immediate workup for hemolysis (ABO/Rh incompatibility, DAT/Coombs test) and total serum bilirubin (TSB).

Physiological jaundice peaks at days 3-5 in term infants, whereas prolonged jaundice (>2 weeks in term, >3 weeks in preterm) necessitates measuring direct/conjugated bilirubin to rule out biliary atresia.

Congenital anomalies like tracheoesophageal fistula (TEF/EA), congenital diaphragmatic hernia (CDH), and gastroschisis/omphalocele demand immediate resuscitation adjustments (e.g., avoid bag-mask ventilation in CDH to prevent lung compression).

APGAR scoring at 1 and 5 minutes guides newborn assessment but is NOT used to determine the initiation of neonatal resuscitation.

Last updated: July 2026

6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies

The transition from intrauterine to extrauterine life requires rapid physiological adaptation. Proficiency in Neonatal Resuscitation Program (NRP 8th Edition) protocols, structured evaluation of neonatal jaundice according to Canadian Paediatric Society (CPS) guidelines, and early recognition of surgical congenital anomalies are essential competencies for the MCCQE Part I.

Neonatal Resuscitation Program (NRP 8th Edition)

Approximately 10% of newborns require assistance to establish breathing at birth, and 1% require intensive resuscitation. NRP emphasizes that hypoxia in neonates is almost exclusively respiratory in origin ; establishing effective lung inflation is the absolute priority.

The "Golden Minute"

The initial steps and evaluation must be completed within 60 seconds of birth .

Initial Assessment (3 Questions):

Term gestation?

Good muscle tone?

Breathing or crying?

If YES to all: Keep with mother (skin-to-skin), dry, cover, clear airway if necessary, routine care.

If NO to any: Move to radiant warmer for initial steps.

Initial Steps (20–30 Seconds):

Warm and maintain normal temperature (36.5°C–37.5°C).

Position head in "sniffing" position to open airway.

Clear secretions from mouth then nose with bulb syringe if obstructed or meconium present.

Dry thoroughly and discard wet linen.

Stimulate by gently rubbing the back or flicking the soles of the feet.

Evaluation of Heart Rate & Respiration:

Assess HR via stethoscope or 3-lead ECG monitor.

Apnea, gasping, OR Heart Rate < 100 bpm: Initiate Positive Pressure Ventilation (PPV) immediately.

Target Oxygen Saturation: Start PPV with 21% O2 (room air) for term infants (≥35 weeks) and 21%–30% O2 for preterm infants (<35 weeks). Connect pulse oximeter to right hand/wrist (pre-ductal) .

  • Target Pre-Ductal SpO2 (NRP 8th Ed) Time After Birth
  • 60% – 65% 1 minute
  • 65% – 70% 2 minutes
  • 70% – 75% 3 minutes
  • 75% – 80% 4 minutes
  • 80% – 85% 5 minutes
  • 85% – 95% 10 minutes
  • Ventilation Corrective Steps: MR. SOPA

If the heart rate is not increasing despite PPV, check chest movement. If chest is not moving adequately, perform MR. SOPA steps:

  • M ask readjustment
  • R eposition head (sniffing position)
  • S uction mouth and nose
  • O pen mouth slightly
  • P ressure increase (increase by 5–10 cm H2O increments up to max 40 cm H2O)
  • A lternative airway (endotracheal tube or laryngeal mask airway)
  • Chest Compressions & Epinephrine

Indication: Heart rate < 60 bpm despite at least 30 seconds of effective PPV that moves the chest (preferably via endotracheal tube).

Technique: Two-thumb encircling-hands technique over lower third of sternum. Depth: 1/3 of AP diameter of chest.

Compression to Ventilation Ratio: 3:1 (90 compressions and 30 breaths per minute = 120 events/min). Increase oxygen to 100% O2 during compressions.

Medications: If HR remains < 60 bpm despite 60 seconds of chest compressions with 100% O2, administer IV/IO Epinephrine (0.02 mg/kg of 0.1 mg/mL [1:10,000]). ETT route is secondary (0.1 mg/kg) while securing IV/IO access.

Neonatal Hyperbilirubinemia & Jaundice

Jaundice affects up to 60% of term and 80% of preterm infants in the first week of life. The clinical imperative is differentiating benign physiological elevation from pathological hyperbilirubinemia that risks kernicterus (acute bilirubin encephalopathy) .

Pathological vs. Physiological Jaundice

Pathological Jaundice (ALWAYS Abnormal):

Onset within the first 24 hours of life .

Rapid rate of rise (> 8.5 µmol/L/hour or > 85 µmol/L/day).

Total Serum Bilirubin (TSB) exceeding phototherapy thresholds on CPS nomograms.

Conjugated (direct) bilirubin > 17 µmol/L (or > 20% of TSB).

Jaundice persisting beyond 14 days in term or 21 days in preterm infants.

Etiologies: Immune hemolysis (ABO incompatibility, Rh isoimmunization), non-immune hemolysis (G6PD deficiency, spherocytosis), sepsis, cephalohematoma breakdown.

Physiological Jaundice:

Onset after 24 hours (typically peaks at days 3–5 in term, up to day 7 in preterm).

Caused by increased red cell mass, shorter RBC lifespan (90 days), and immature hepatic glucuronosyltransferase (UGT1A1) conjugation.

Breastfeeding Jaundice (Lack of Breast Milk):

Onset days 2–5. Caused by insufficient milk intake → dehydration, decreased stooling → increased enterohepatic circulation of bilirubin. Management: Increase feeding frequency, lactation support.

Breast Milk Jaundice:

Onset days 4–7, peaking at 2–3 weeks. Caused by factors in breast milk (e.g., beta-glucuronidase) that promote intestinal deconjugation. Benign; breastfeeding should continue.

Conjugated Hyperbilirubinemia & Biliary Atresia

Exam Trap: Any infant with jaundice lasting past 2 weeks of age MUST have total and direct (conjugated) bilirubin measured. Conjugated hyperbilirubinemia is NEVER physiological.

Biliary Atresia is a progressive idiopathic obliterative cholangiopathy of extrahepatic bile ducts.

Presentation: Jaundice extending beyond 2 weeks, acholic (pale/clay-colored) stools , dark tea-colored urine, hepatomegaly.

Diagnosis: Abdominal ultrasound (triangular cord sign, absent/contracted gallbladder), intraoperative cholangiography (gold standard).

Management: Urgent Kasai portoenterostomy performed before 60 days of life to restore bile drainage and prevent irreversible biliary cirrhosis.

Common Surgical Congenital Anomalies

Anomaly Clinical Features Diagnostic Findings Immediate Management

Congenital Diaphragmatic Hernia (CDH) Severe respiratory distress at birth, scaphoid abdomen, bowel sounds heard in chest CXR shows bowel loops in hemithorax, mediastinal shift DO NOT use bag-mask ventilation! Immediate ET intubation, NGT decompression, ECMO/surgery

Tracheoesophageal Fistula / Esophageal Atresia (TEF/EA) Excessive frothy drooling, choking/cyanosis on 1st feed; associated with VACTERL Inability to pass rigid NGT into stomach (coils on CXR) Keep NGT on continuous suction, elevate head of bed 45°, NPO, IV fluids, surgical repair

Gastroschisis Abdominal wall defect lateral to umbilicus (usually right); NO covering sac Exposed bowel loops inflamed by amniotic fluid exposure Wrap exposed bowel in sterile saline bowel bag, IV fluids, IV antibiotics, primary/staged reduction

Omphalocele Midline defect through umbilical ring; covered by peritoneal sac Cord inserts into apex of sac; high association with Trisomies 13/18/21 & Beckwith-Wiedemann Cover sac with sterile moist dressing, genetic workup, rule out cardiac anomalies, delayed closure

Duodenal Atresia Bilious vomiting on day 1; high association with Down Syndrome (Trisomy 21) Abdominal X-ray shows classic "Double Bubble" sign NPO, NGT decompression, fluid/electrolyte correction, duodenoduodenostomy

Loading diagram... NRP 8th Edition Resuscitation & Jaundice Management Flowchart